Clinical Orthopaedics and Related Research

, 466:2176

Dendritic Cell-Ewing’s Sarcoma Cell Hybrids Enhance Antitumor Immunity

Symposium: Molecular Genetics in Sarcoma

DOI: 10.1007/s11999-008-0348-7

Cite this article as:
Guo, W., Guo, Y., Tang, S. et al. Clin Orthop Relat Res (2008) 466: 2176. doi:10.1007/s11999-008-0348-7

Abstract

Given the effective immunotherapy of DC-based vaccine in other cancers, we hypothesized DC-based vaccines would induce effective immune responses against Ewing’s sarcoma. To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing’s sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing’s sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing’s sarcoma, using an A673 cell line as a model. The hybrids were generated by electrofusion with fusion efficiency and viability determined by flow cytometry and fluorescent microscopy analyses. By interferon-γ secretion assay, the capacity of hybrids to stimulate cytotoxic T-lymphocytes (CTLs) is higher than that of other antigen-loading methods showing stronger tumor antigen-specific CTL cytotoxicity to A673. By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing’s sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice. However, the hybrids most inhibited the subcutaneous tumor growth in SCID mice compared with dendritic cells pulsed with other loading methods. The data suggest A673 cells respond to dendritic cell-based immunotherapy.

Copyright information

© The Association of Bone and Joint Surgeons 2008

Authors and Affiliations

  • Wei Guo
    • 1
  • Yi Guo
    • 2
  • Shun Tang
    • 1
  • Huayi Qu
    • 1
  • Hui Zhao
    • 1
  1. 1.Musculoskeletal Tumor CenterPeking University People’s HospitalBeijingPeople’s Republic of China
  2. 2.Orthopaedic Department, UCI Medical CenterUniversity of California at IrvineIrvineUSA